Clinical trial
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT02740634 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 31, 2016
- Completion date
- March 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, alzheimer disease, early onset, amnestic disorder, amnestic mild cognitive disorder, amnestic symptoms, atypical alzheimer's disease, logopenic progressive aphasia (lpa), posterior cortical atrophy (pca)